Original Source(s)
Related Content
Smartwatch May Track AD Status in Children
Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.
May 5, 2026
-
3 min
FDA Drops Age Limit for Neffy
Needle-free epinephrine expands access for younger children meeting weight criteria
March 27, 2026
-
2 min
Oral TYK2 Inhibition in Atopic Dermatitis
Phase 2 trial evaluated once-daily oral TYK2 inhibition in adults with moderate to severe AD.
February 5, 2026
-
4 min